evenfolioETF Details
iShares·Health·IBB · Nasdaq
iShares Biotechnology ETF (IBB)
- Price
- $217.61
- —30 Oct 2026
- Assets
- $11.2B
- Total net assets
- Expense ratio
- 0.44%
- Category 1.00%
- Yield
- 0.16%
- Trailing distributions
- 1Y return
- 38.6%+9.8%
- Category 28.8%
- 3Y CAGR
- 24.7%+3.2%
- Category 21.5%
- 5Y CAGR
- 6.7%+2.6%
- Category 4.1%
Loading NAV history…
iShares Biotechnology ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +3.4% | +16.7% | +30.1% | +29.1% | +38.6% | +24.7% | +6.7% | +9.9% | +7.6% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -0.2% | +6.8% | +7.1% | +8.6% | +9.8% | +3.2% | +2.6% | -0.9% | -4.0% |
Holdings
The 10 largest positions make up 49.3% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| GILD | Gilead Sciences Inc | 8.08% |
| AMGN | Amgen Inc | 7.78% |
| VRTX | Vertex Pharmaceuticals Inc | 7.62% |
| REGN | Regeneron Pharmaceuticals Inc | 5.28% |
| MRNA | Moderna Inc | 4.94% |
| NTRA | Natera Inc | 3.91% |
| ARGX | argenx SE ADR | 3.74% |
| ILMN | Illumina Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.33% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 5.9
- P/S
- 7.4
- P/CF
- 20.9
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Cash0.1%
ETF details
- Issuer
- iShares
- Category
- Equity · Health
- Ticker
- IBB
- Exchange
- Nasdaq
- Inception
- 5 Feb 2001 (25.7 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.44% (category 1.00%)
- Holdings turnover
- 27% (category 51%)
- Distribution yield
- 0.16%
- Beta, 3 years
- 0.70
- Total net assets
- $11.2B
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- XBI · State Street SPDR S&P Biotech ETFState Street Investment Management · $10.4B · ER 0.35%5Y 4.7%
- IXJ · iShares Global Healthcare ETFiShares · $4.3B · ER 0.38%5Y 6.7%
- IYH · iShares U.S. Healthcare ETFiShares · $4B · ER 0.37%5Y 7.4%
- FHLC · Fidelity MSCI Health Care Index ETFFidelity Investments · $3.5B · ER 0.08%5Y 7.2%
- IHI · iShares U.S. Medical Devices ETFiShares · $3.4B · ER 0.37%5Y -3.1%
- FBT · First Trust NYSE Arca Biotechnology Index FundFirst Trust · $3B · ER 0.55%5Y 11.4%